Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (beijing) Co., Ltd.

Clinical trials sponsored by Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (beijing) Co., Ltd., explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New Gene-Silencing drug takes first step in human safety trial

Disease control Ongoing

This early-stage trial is testing a new drug called RG002C0106 in 30 healthy adults to see if it is safe and how the body processes it. The drug uses RNA interference to silence a gene involved in the immune system's complement pathway. The study is randomized and placebo-control…

Phase: PHASE1 • Sponsor: Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC